Since increased follistatin serum levels were found in thyroid cancer patients and correlated with advanced tumor aggressiveness [43], a strong reduction of follistatin secretion may support a role for macrophages in the reduced invasion and migration of C3948 cancer cells observed. This evidence concerns the gene FST and thyroid gland carcinoma.